Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Owkin

Request full access

Collaborative research platform and unique AI drug development solutions that make precision medicine a reality

Paris, FranceFounded 2016Biotech & Life Sciences

Owkin in the Paris ecosystem

Live from Dealroom

The Owkin office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

28 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • NJF Capital
  • Shana Fisher
  • Jean-Paul Clozel
  • Nicole Junkermann

Series A10 investors entered at this stage

Series B and later14 investors entered at this stage

  • Bristol-Myers Squibb
  • CNRS Innovation
  • SISTAFUND
  • INRIA
  • OTB Ventures
  • Sanofi
  • Google for Startups Accelerator
  • Alpha Intelligence Capital
  • École normale supérieure – PSL University
  • Serena
  • French National Centre for Scientific Research - CNRS
  • EIT Health
  • Karista
  • PSL University

Ownership

Share of equity by holder

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (Mar/2026). Percentages are indicative.

27.5% Founders

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Employees mapped 430 incl. 87 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 64 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 10 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$3M

9 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Owkin was the backer or acquirer, 2023–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Owkin's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Owkin's portfolio, mapped.

        Stage
        Period
        3 of 3 deals

        See Owkin on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.